Riktkurs.nu
EN | SV
VNV GlobalMid Cap
Stockholm Stock Exchange | Mid Cap
Xvivo Perfusion
+20.78%
Latest
+28.77%
3 months
Pareto SecuritiesCarnegieDanske BankBryan GarnierDanske Bank Markets

Price Targets For Xvivo Perfusion

AnalystPrice TargetDateUpside
Pareto Securities340 SEKApr 25
+20.78%
Carnegie385 SEKApr 25
Danske Bank403 SEKOct -22
Bryan Garnier400 SEKFeb -22
Danske Bank Markets448 SEKJun -21

About The Company

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.
Xvivo Perfusion

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2023